The aim of the present study was to detect over-expression of ALK protein with the Ventana IHC test and to examine the associations of ALK rearrangement with clinicopathologic characteristics and treatment outcomes in patients with early-stage lung adenocarcinoma. This evidence concerns the gene ALK and lung adenocarcinoma.